Three-day dendritic cells for vaccine development: antigen uptake, processing and presentation. - Wikidata - wikimedia - TriplyDB

Three-day dendritic cells for vaccine development: antigen uptake, processing and presentation.

Three-day dendritic cells for vaccine development: antigen uptake, processing and presentation.

http://www.wikidata.org/entity/Q34202646

about

An upstream open reading frame regulates LST1 expression during monocyte differentiation.A novel and effective method to generate human porcine-specific regulatory T cells with high expression of IL-10, TGF-β1 and IL-35 Preparation of triple-negative breast cancer vaccine through electrofusion with day-3 dendritic cells Codon optimization of the human papillomavirus E7 oncogene induces a CD8+ T cell response to a cryptic epitope not harbored by wild-type E7 Dendritic cell-based vaccination for renal cell carcinoma: challenges in clinical trials.Interleukin-15 dendritic cells as vaccine candidates for cancer immunotherapy.New generation dendritic cell vaccine for immunotherapy of acute myeloid leukemia.Enhanced stimulation of human tumor-specific T cells by dendritic cells matured in the presence of interferon-γ and multiple toll-like receptor agonists.Advances and challenges: dendritic cell vaccination strategies for glioblastoma.Dendritic Cell Strategies for Eliciting Mutation-Derived Tumor Antigen Responses in Patients.Complex evaluation of human monocyte-derived dendritic cells for cancer immunotherapy.NOD/scid IL-2Rg(null) mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivo.An in vitro human skin test for assessing sensitization potential.In vitro and in vivo antitumor effects of 50 to 100-KDa components from B16 melanoma culture supernatant.The antiviral immune response in human conventional dendritic cells is controlled by the mammalian target of rapamycin.Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?CIMT 2013: advancing targeted therapies--report on the 11th Annual Meeting of the Association for Cancer Immunotherapy, May 14-16 2013, Mainz, Germany.Unbiased Identification of T-Cell Receptors Targeting Immunodominant Peptide-MHC Complexes for T-Cell Receptor Immunotherapy.Enhanced immune response induced by P5 HER2/neu-derived peptide-pulsed dendritic cells as a preventive cancer vaccine.Induction of porcine-specific regulatory T cells with high specificity and expression of IL-10 and TGF-β1 using baboon-derived tolerogenic dendritic cells.

P2860

Q31160936-F46C125A-AFBD-47B5-9E72-72FD417D0DA1 Q33822472-A189B227-631F-4DE7-8267-082E2BFF821B Q33921487-3EC5A338-423E-451F-B382-88E186DC0935 Q35208290-C7ABEED5-4A07-456D-8689-B7EF9A10B711 Q38059516-DFB72318-57DE-4A78-95D8-E01905148EB5 Q38115438-4214A6C3-7E96-49EF-9D83-2FB6A639BFA6 Q38245928-B5199A5B-A248-499E-8EB9-DC6EAC6767F8 Q38672403-E84AB080-67BB-4D6E-B3C5-83C795A22D97 Q38921652-13FEE45F-44AF-4D36-A6C7-B6E19C9837EE Q39243064-FA197201-976E-47C9-8F06-0894F7810775 Q39299639-3C67E1F2-BD77-40B6-9A0F-97569173C854 Q39390511-CFF19054-5A4C-4BD0-9D09-F6CFD5B94C7A Q40648987-B1748BE2-AD8B-4A94-A3DC-5F16F9D23A97 Q41550106-CC7F334B-3EF2-4642-80DF-069A57445F38 Q42207619-E5575F62-94D7-458C-845D-4F354FEC7242 Q42245307-74E88A86-A506-4CB2-863A-91DE4596CCC3 Q42723974-A79344E7-9C5C-48D6-9E2A-A492E6D4ADB5 Q45872498-633385CB-C853-470F-8891-1C701149C53E Q47139657-9D164C1F-BD81-41C5-973B-FB600A054C2F Q47618676-C45C878E-8EBF-41F5-AD12-D389DB17F3E0

P2860

Three-day dendritic cells for vaccine development: antigen uptake, processing and presentation.

http://www.wikidata.org/entity/Q34202646

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Three-day dendritic cells for ...... , processing and presentation.

@ast

Three-day dendritic cells for ...... , processing and presentation.

@en

Three-day dendritic cells for ...... , processing and presentation.

@nl

type

label

Three-day dendritic cells for ...... , processing and presentation.

@ast

Three-day dendritic cells for ...... , processing and presentation.

@en

Three-day dendritic cells for ...... , processing and presentation.

@nl

prefLabel

Three-day dendritic cells for ...... , processing and presentation.

@ast

Three-day dendritic cells for ...... , processing and presentation.

@en

Three-day dendritic cells for ...... , processing and presentation.

@nl

P1433

Q34202646-AC85E08C-55E3-4BE5-93AA-DBB5AFF41A31

P1476

Q34202646-A7D7A23F-8243-481F-81E4-0D6E9802A9E6

P2093

Q34202646-1681772E-25AE-4810-8D39-90B814CDF86F

Q34202646-5D4142C1-5B7E-4BBD-942B-68953CE3BC26

Q34202646-9FBCCE74-2DBC-433B-9F3A-92A58594F8E4

Q34202646-EE945B17-2228-4ACD-8F7C-16A97A0BC4F3

Q34202646-F377DB61-55AD-4A1F-929A-E6ECEC20EBAF

Q34202646-F858AC2F-9EED-4931-B219-6BF8217E9DCC

P2860

Q34202646-08F6DD49-B421-4BBB-BEA4-817DB06E0E61

Q34202646-09F8ED32-E7BB-44DD-A265-6EF2F51A3FEE

Q34202646-0A602FD8-8409-491D-81B2-34033F38AD01

Q34202646-17F8FA38-D89D-4186-B41E-3FF24C5CB849

Q34202646-18DA3F47-751B-4E43-9770-8090E9C83B08

Q34202646-28B274D1-7D42-43F5-B739-6EFEB0378542

Q34202646-2AF67745-7423-4DFD-BB29-33590AE4885D

Q34202646-354816E6-7A62-4C17-8FA0-3DECCD70C546

Q34202646-37EF989E-2646-40E2-BDC6-4E778B376AAD

Q34202646-483F8564-ED75-4717-BE0E-E875F2C0C193

P2888

Q34202646-8EF7E67F-118D-4102-9201-CDEE526771C7

P304

Q34202646-327EE075-21D3-43CE-9FE9-49FB12EC24B4

P31

Q34202646-08505A31-DBB8-4BED-9357-9898F781CD3F

P356

Q34202646-D87C574A-7551-415D-9EF3-F5C4F2B5E3D9

P478

Q34202646-F754853B-6BDD-4DDC-94A2-D84E46C3E515

P577

Q34202646-8598BEF8-3A97-49AF-9DE7-6F262EA37FED

P5875

Q34202646-21B489AA-4FC0-49D2-80F3-016CB034D7A9

P698

Q34202646-1657F852-ECC5-4209-B773-913CB391F1B9

P932

Q34202646-A691AAB6-D380-46E9-A94B-A666B0F0D053

P356

P1433

Journal of Translational Medicine

P1476

Three-day dendritic cells for ...... , processing and presentation.

@en

P2093

Bernhard Frankenberger

http://www.w3.org/2001/XMLSchema#string

Christiane Geiger

http://www.w3.org/2001/XMLSchema#string

Dolores J Schendel

http://www.w3.org/2001/XMLSchema#string

Maja Bürdek

http://www.w3.org/2001/XMLSchema#string

Stefani Spranger

http://www.w3.org/2001/XMLSchema#string

Susanne Wilde

http://www.w3.org/2001/XMLSchema#string

P2860

Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation

Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products

Development of a new protocol for 2-day generation of mature dendritic cells from human monocytes

Dendritic cells and the control of immunity

Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha

Dendritic cells: specialized and regulated antigen processing machines

Tolerogenic dendritic cells

B7-H1 (programmed death-1 ligand) on dendritic cells is involved in the induction and maintenance of T cell anergy.

A full scale comparative study of methods for generation of functional Dendritic cells for use as cancer vaccines.

Evaluation of 3 clinical dendritic cell maturation protocols containing lipopolysaccharide and interferon-gamma

P2888

P304

90

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1479-5876-8-90

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

47335380

http://www.w3.org/2001/XMLSchema#string

P698

20920165

http://www.w3.org/2001/XMLSchema#string

P932

2955579

http://www.w3.org/2001/XMLSchema#string